SCHEMBL845603

SCHEMBL845603

c1ccc2sc(-c3cc4ccccc4s3)cc2c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 2/20 0.63
HSD17B1 P14061 1/20 0.55
HSD17B2 P37059 1/20 0.55
CA9 Q16790 4/20 0.53
CA2 P00918 3/20 0.53
CA1 P00915 2/20 0.53
NQO1 P15559 1/20 0.53
NQO2 P16083 1/20 0.53
CYP2A6 P11509 4/20 0.52
ASIC3 Q9UHC3 1/20 0.52
LOXL2 Q9Y4K0 1/20 0.52
MGLL Q99685 1/20 0.52
CHRM2 P08172 1/20 0.50
CHRM4 P08173 1/20 0.50
CHRM5 P08912 1/20 0.50
CHRM1 P11229 1/20 0.50
CHRM3 P20309 1/20 0.50
BCL2L1 Q07817 1/20 0.50
ERN1 O75460 1/20 0.49
CYP19A1 P11511 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29732980 1.00 APP (0.63) APPHSD17B1HSD17B2CA9CA2
SCHEMBL2149612 0.95 APP (0.59) APPHSD17B1HSD17B2CA9CA2
SCHEMBL5148513 0.93 APP (0.57) APPHSD17B1HSD17B2CA9CA2
SCHEMBL27651550 0.93 APP (0.57) APPHSD17B1HSD17B2CA9CA2
SCHEMBL2150464 0.93 APP (0.57) APPHSD17B1HSD17B2CA9CA2
SCHEMBL32677328 0.87 APP (0.81) APPHSD17B1HSD17B2CA9CA2
SCHEMBL27989389 0.87 APP (0.57) APPHSD17B1HSD17B2CA9CA2
SCHEMBL27159530 0.87 APP (0.81) APPHSD17B1HSD17B2CA9CA2
SCHEMBL19133572 0.87 APP (0.57) APPHSD17B1HSD17B2CA9CA2
SCHEMBL12854022 0.85 APP (0.55) APPHSD17B1HSD17B2CA9CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 201 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3909964-B1 ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO LTD (KR) 2025-10-08 EP claimed
US-20210355148-A1 ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2021-11-18 US claimed
EP-3909964-A2 ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE Samsung Electronics Co., Ltd. (KR) 2021-11-17 EP claimed
US-10858334-B2 Method for aerobic oxidative coupling of thiophenes with a ligand-supported palladium catalyst WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2020-12-08 US claimed
US-20190210993-A1 Method for Aerobic Oxidative Coupling of Thiophenes with a Ligand-Supported Palladium Catalyst NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2019-07-11 US claimed
EP-1300430-B1 Mono-, oligo- and polymers of benzo(b)thiophene and 2,2'-bisbenzo(b)thiophene and their use as charge transport materials MERCK PATENT GMBH (DE) 2010-07-07 EP claimed
US-6695978-B2 FOR USE IN OPTICAL, ELECTROOPTICAL OR ELECTRONIC DEVICE, LIKE FOR EXAMPLE COMPONENTS OF INTEGRATED CIRCUITRY, FIELD EFFECT TRANSISTORS (FET) FOR EXAMPLE AS THIN FILM TRANSISTORS IN FLAT PANEL DISPLAY OR FOR RADIO FREQUENCY IDENTIFICATION TAGS MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 2004-02-24 US claimed
US-20030085381-A1 Mono-, oligo- and polymers of benzo[b]thiophene and 2,2'-bisbenzo[b]thiophene and their use as charge transport materials MERCK PATENT GMBH (DE) 2003-05-08 US claimed
EP-1300430-A1 Mono-, oligo- and polymers of benzo[b]thiophene and 2,2'-bisbenzo[b]thiophene and their use as charge transport materials MERCK PATENT GmbH (DE) 2003-04-09 EP claimed
EP-1069114-A2 Sulfonamides and derivatives thereof that modulate the activity of endothelin TEXAS BIOTECHNOLOGY CORPORATION (US) 2001-01-17 EP claimed
EP-0870764-A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin TEXAS BIOTECHNOLOGY CORPORATION (US) 1998-10-14 EP claimed
EP-0699191-A1 SULFONAMIDES AND DERIVATIVES THEREOF THAT MODULATE THE ACTIVITY OF ENDOTHELIN TEXAS BIOTECHNOLOGY CORPORATION (US) 1996-03-06 EP claimed
WO-1994027979-A1 SULFONAMIDES AND DERIVATIVES THEREOF THAT MODULATE THE ACTIVITY OF ENDOTHELIN IMMUNOPHARMACEUTICS, INC. (US) 1994-12-08 WO claimed
EP-4281058-B1 FUNCTIONALIZED LONG-CHAIN DICARBOXYLIC ACIDS, AND THEIR USE FOR TREATMENT OF KIDNEY DISEASES ESPERVITA THERAPEUTICS INC (US) 2026-03-18 EP disclosed
US-12570600-B2 Multifunctional linker compounds 20Bloc, Inc. (US) 2026-03-10 US disclosed
EP-4695266-A1 SUBSTITUTED ALKANOIC-DIACIDS COMPOUND AND COMPOSITION AND USE THEREOF Meta Pharmaceuticals (HK) Limited (HK) 2026-02-18 EP disclosed
US-5571821-A CARDIOVASCULAR DISORDERS TO MODULATE ENDOTHELIN, HYPOTENSIVE AGENTS AND VASOCONSTRICTION TEXAS BIOTECHNOLOGY CORPORATION (US) 1996-11-05 US disclosed
EP-0699191-A1 SULFONAMIDES AND DERIVATIVES THEREOF THAT MODULATE THE ACTIVITY OF ENDOTHELIN TEXAS BIOTECHNOLOGY CORPORATION (US) 1996-03-06 EP disclosed
WO-1994027979-A1 SULFONAMIDES AND DERIVATIVES THEREOF THAT MODULATE THE ACTIVITY OF ENDOTHELIN IMMUNOPHARMACEUTICS, INC. (US) 1994-12-08 WO disclosed
US-5171891-A Using sulfur containing oxy acids and their salts ALLIED-SIGNAL INC. (US) 1992-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10858334-B2 Method for aerobic oxidative coupling of thiophenes with a ligand-supported palladium catalyst PPOX, TST, COX6C APP 3471/4885HSD17B1 1177/4885HSD17B2 1085/4885
US-20190210993-A1 Method for Aerobic Oxidative Coupling of Thiophenes with a Ligand-Supported Palladium Catalyst PPOX, TST, COX6C APP 3471/4885HSD17B1 1177/4885HSD17B2 1085/4885
US-20030085381-A1 Mono-, oligo- and polymers of benzo[b]thiophene and 2,2'-bisbenzo[b]thiophene and their use as charge transport materials SLCO2B1, SLCO2A1, CLTB APP 3951/4885HSD17B1 4053/4885HSD17B2 3741/4885
US-12570600-B2 Multifunctional linker compounds CHN2, RCC2, COG1 APP 4023/4885HSD17B1 1318/4885HSD17B2 1626/4885
US-20210355148-A1 ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE CYBA, C1S, CYC1 APP 2897/4885HSD17B1 1529/4885HSD17B2 2369/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.